Bioceres Crop Solutions Corp. (BIOX) is a Agricultural Inputs company in the Basic Materials sector, currently trading at $0.59. It has a SharesGrow Score of 49/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of BIOX = $1,550.22 (+264307.3% from the current price, the stock appears undervalued). Analyst consensus target is BIOX = $2 (+241.1% upside).
Valuation: BIOX trades at a trailing Price-to-Earnings (P/E) of -0.2 (S&P 500 average ~25).
Financials: revenue is $333M, +3.4%/yr average growth. Net income is $52M (loss), growing at -473.1%/yr. Net profit margin is -15.5% (negative). Gross margin is 39.1% (+0.6 pp trend).
Balance sheet: total debt is $277M against $263M equity (Debt-to-Equity (D/E) ratio 1.05, moderate). Current ratio is 0.91 (tight liquidity). Debt-to-assets is 36.2%. Total assets: $764M.
Analyst outlook: 4 / 5 analysts rate BIOX as buy (80%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 30/100 (Fail), Past 50/100 (Partial), Health 17/100 (Fail), Moat 40/100 (Fail), Future 94/100 (Pass), Income 10/100 (Fail).
